SynthesisCancer control : journal of the Moffitt Cancer Center

Survival Outcomes and Safety of Programmed Cell Death/Programmed Cell Death Ligand 1 Inhibitors for Unresectable Hepatocellular Carcinoma: Result From Phase III Trials.

Linyan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.